References
- Bjerkelund Chr. T. The effect of phenylindanedione on plasma-prothrombin and factor V and a comparison with the effect of dicoumarol. Scan-dinav. J. Clin. & Lab. Investigation 1950; 2: 83
- Eronstein M. R, Witkind E. Clinical experience with the anticoagulant tromexan. Am. J. M. Sc. 1951; 222: 677
- Douglas A. S, Brown A. Effect of vitamin-K preparations on hypoprothrombinaemia induced by dicoumarol and tromexan. Brit. Med. J. 1952; 1: 412
- Guéguen J. E, Soulier J. P. Action de la P. I. D. sur le taux de la prothrombine. Rev. d'hemat. 1948; 3: 180, 185
- Holmes R. W, Love J. Suicide attempt with warfarin, a bishydroxycoumarin-like Rodenti-cide. J.A.M.A. 1952; 148: 935
- Jaques L. B., Gordon E., Lepp E. A new prothrombopenic drug, phenylindanedione. Canad. M. A. J. 1950; 62: 465
- Jaques L. B., Taylor E., Lepp E. Action of phenylindanedione on prothrombin time. Federation Proc. 1949; 8: 81
- Kabat H., Stohlman E. F., Smith M. I. Hypoprothrombinaemia induced by administration of indanedione derivatives. J. Pharmacol. 1944; 80: 160
- Owren P. A. A quantitative one-stage method for the essay of prothrombin. Scandinav. J. Clin. & Lab. Investigation 1949; 1: 81
- Scarrone L. A., Beck D. F., Wright I. S. A comparative evaluation of tromexan and dicoumarol in the treatment of thrombo-em-bolic conditions - based on experience with 514 patients. Circulation 1952; 4: 489
- Stragnell R. Intravenous emulsified vitamin K1 in the treatment of coumarin-induced hypoprothrombinaemia. Am. Heart J. 1952; 44: 124
- Toohey M. Antagonisms of anticoagulant dicoumarol, tromexan and P.I.D. by vitamin Ki. Brit. Med. J. 1952; 1: 687